Abbie Lennox serves as the Executive Vice President and a key member of the Executive Committee at Bayer Consumer Health, where she leads the Trust & Science division, focusing on Regulatory, Medical, Safety, Quality, and Compliance. In her pivotal role, Abbie is instrumental in driving...
Abbie Lennox serves as the Executive Vice President and a key member of the Executive Committee at Bayer Consumer Health, where she leads the Trust & Science division, focusing on Regulatory, Medical, Safety, Quality, and Compliance. In her pivotal role, Abbie is instrumental in driving product innovation and lifecycle management, ensuring that Bayer’s extensive portfolio of consumer health products meets the highest standards of safety and efficacy. With a robust team of over 900 professionals spread across 50 geographies, she fosters a culture of performance motivation and collaboration, empowering her team to navigate the complexities of the pharmaceutical industry with agility and precision.
Abbie's expertise lies in leveraging science-based principles to address the multifaceted challenges of regulatory submissions and compliance, particularly within the fast-paced consumer health and FMCG sectors. Her strategic vision has been critical in launching reliable self-care solutions that resonate with consumers, enhancing their health and well-being. She is adept at integrating product and regulatory strategy, ensuring that Bayer not only meets but exceeds industry standards.
Key projects under her leadership include the development of innovative consumer health products that prioritize safety and quality, as well as initiatives aimed at enhancing the regulatory landscape for self-care solutions. Abbie’s strong communication skills and commitment to people development have positioned her as a respected leader in the industry, driving Bayer’s mission to empower consumers through science-backed health solutions. Her ability to navigate complex regulatory environments while maintaining a consumer-centric approach underscores her significant impact on Bayer's success in the global marketplace.
